Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) - Total debt
Total debt on the balance sheet as of December 2023 : $2.79 M
According to Curis's latest financial reports the company's total debt is $2.79 M. A company’s total debt is the sum of all current and non-current debts.
Curis - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.79 M | -29.1% |
| 2022-12-31 | $3.94 M | -21.81% |
| 2021-12-31 | $5.04 M | -34.22% |
| 2020-12-31 | $7.66 M | 4515.66% |
| 2019-12-31 | $0.16 M | -99.53% |
| 2018-12-31 | $35.48 M | -14.61% |
| 2017-12-31 | $41.55 M | 109.24% |
| 2016-12-31 | $19.86 M | -17.82% |
| 2015-12-31 | $24.16 M | -14.61% |
| 2014-12-31 | $28.29 M | -7.38% |
| 2013-12-31 | $30.55 M | 2.4% |
| 2012-12-31 | $29.83 M | |
| 2008-12-31 | $N/A | -100% |
| 2007-12-31 | $0.4 M | -79.6% |
| 2006-12-31 | $1.97 M | -66.06% |
| 2005-12-31 | $5.83 M | -14.88% |
| 2004-12-31 | $6.85 M | 21.12% |
| 2003-12-31 | $5.65 M | -54.44% |
| 2002-12-31 | $12.41 M | 17.48% |
| 2001-12-31 | $10.56 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 2,535,512.03% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.46 B | 1,483,937.22% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $28.84 M | 932.21% | 🇺🇸 USA |
 Exelixis EXEL | $0.18 B | 6,698.28% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.54 M | -9.02% | 🇺🇸 USA |
 Cel-Sci
CVM | $13.09 M | 368.83% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.86 B | 30,687.40% | 🇺🇸 USA |